Mr. Speaker, we have been consistent in communicating our delivery window in Q1 of 2021. Given the number of variables and the novelty of the process, we are still communicating a delivery window in Q1 of 2021. We do not anticipate any impact on delivery of the Pfizer vaccine to Canada, which is expected to begin in the first quarter of 2021 as planned.
In the House of Commons on December 4th, 2020. See this statement in context.